Grant: CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer
Toronto Metropolitan University
$65,000.00
Metabolic control of glycogen synthase kinase 3ß nuclear translocation by lysosomal signals drives breast cancer cell proliferation and survival.
EF 2023-24
Résumé
Despite recent advances, some types of breast cancer remain difficult to treat. New effective therapies are urgently needed. Many breast cancer cells differ from healthy cells in their metabolism – their ability to make and use sugars, lipids and amino acids. Breast cancer cells also have metabolic versatility – the ability to sense and adapt to the scarce levels of nutrients found in tumors, which makes some breast tumors hard to treat. We will study a new cancer cell signaling system that we discovered, by which breast cancer cells sense their own metabolic state, allowing them to adapt, grow and survive. Understanding the molecular mechanisms of this new metabolism sensing system of cancer cells will allow identification of new drug targets that may be effective in developing new more effective breast cancer therapies.
Programme
CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
516990
Name
Antonescu Costin N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Metabolic control of glycogen synthase kinase 3ß nuclear translocation by lysosomal signals drives breast cancer cell proliferation and survival.
Programtype2
Operating Grants
Orgnameinp2
Toronto Metropolitan University
Cihramount2
$65,000
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer
Keyworddelim
Breast Cancer
Abstract
Despite recent advances, some types of breast cancer remain difficult to treat. New effective therapies are urgently needed. Many breast cancer cells differ from healthy cells in their metabolism – their ability to make and use sugars, lipids and amino acids. Breast cancer cells also have metabolic versatility – the ability to sense and adapt to the scarce levels of nutrients found in tumors, which makes some breast tumors hard to treat. We will study a new cancer cell signaling system that we discovered, by which breast cancer cells sense their own metabolic state, allowing them to adapt, grow and survive. Understanding the molecular mechanisms of this new metabolism sensing system of cancer cells will allow identification of new drug targets that may be effective in developing new more effective breast cancer therapies.
Competitiondate
202402
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Antonescu, Costin N
Approvedterm
2 ans 0 mois
Cihrcontribution2
ICR~ $65,000~ $0~